Observe Medical successfully delivers ultrasound probes to all of Fresenius Kidney Care’s educational centers in the USA
Oslo, 28 April 2022 – Observe Medical ASA ("the Company" or "Observe Medical") today announces that it has delivered an additional 58 Biim ultrasound probes to Fresenius Kidney Care in the US, completing the delivery of a total of 260 ultrasound probes in the first phase of the delivery to Fresenius Kidney Care as planned. As part of the partnership agreement announced in January this year, Observe Medical has delivered the final batch of Biim ultrasound probes to the educational centers of Fresenius Kidney Care, a leading provider of kidney care services in the US. The educational